Healthtech Startups

Kismet operates a digital marketplace connecting users with disability and healthcare services. The platform addresses fragmentation in healthcare systems by creating a connected ecosystem that improves access to care and reduces administrative burden.

5 investors

Koa Health develops a unified digital mental health platform that delivers evidence-based treatment programs and clinical interventions. The company serves healthcare organizations, medical institutions, and patients seeking comprehensive mental health care validated through randomized controlled trials and clinical research.

5 investors

Koala is an online pharmacy that sells vet-approved medications, supplements, and health products for pets, with free shipping on orders over $45. The company serves pet owners seeking convenient access to prescription and over-the-counter veterinary medications and health products.

5 investors

KODE provides a platform connecting medical coders with healthcare providers, offering coders flexible income opportunities while helping providers manage staffing and workflow needs in the healthcare industry.

5 investors

Koltin operates a membership program that includes major medical expense insurance underwritten by BBVA Seguros Salud, offering preventive health services, community access, and controlled annual renewal increases based on preventive care.

5 investors

Kry is a digital healthcare provider offering remote consultations via app and in-person visits at physical clinics across Sweden. The platform serves patients seeking medical advice, prescriptions, and ongoing care coordination for acute and chronic conditions.

5 investors

Lamar Health provides workflow automation software for specialty pharmacies and infusion organizations, enabling teams to manage prior authorization processes and patient access workflows. The platform integrates with existing pharmacy and EHR systems to reduce manual work, delays, and denials while improving staff efficiency and patient treatment initiation times.

5 investors

Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation. The company is a medical device developer based in the United States.

5 investors

Latica provides a secure data collaboration platform for healthcare organizations and research teams, comprising a Trusted Data Environment and Data Exchange that enable analysis of anonymized medical data while maintaining patient privacy and data ownership.

5 investors

Lena is an AI voice and SMS platform for healthcare patient outreach, handling outbound multi-dialing calls, two-way texting, voicemails, and inbound callbacks to enroll patients in care programs. It manages eligibility verification, consent capture, callback scheduling, and live transfers to staff, with real-time performance analytics and multilingual support.

5 investors

LetsGetChecked provides at-home healthcare including lab testing, virtual consultations, and prescription fulfillment, backed by its own manufacturing, logistics, and lab analysis infrastructure plus proprietary clinical and analytics software. It serves individual patients and over 5,000 corporate and healthcare partners globally.

5 investors

Liberate Medical develops VentFree, a non-invasive respiratory muscle stimulator that uses neuromuscular electrical stimulation to contract abdominal wall muscles in synchrony with exhalation in mechanically ventilated patients. The device is intended to reduce respiratory muscle atrophy and potentially shorten the duration of mechanical ventilation and ICU stays for critical care patients.

5 investors

Light Line Medical develops visible light technology for catheters that reduces infections and improves patient outcomes in minimally invasive medical procedures. The company serves healthcare providers and patients requiring catheter-based treatments across organ, vascular, and lymphatic systems.

5 investors

Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale. It serves therapeutics discovery and development, including antibody, cell therapy, immunotherapy, and regenerative medicine research.

5 investors

LightHearted AI develops wearable sensors and accompanying algorithms that continuously record ECG and blood pressure. The company targets clinicians who want to identify cardiac conditions earlier through screening that takes place outside of hospital or clinic settings.

5 investors

Lilac provides AI-powered predictive analytics to healthcare organizations, helping them identify patients at risk and improve quality outcomes in value-based care models. As part of Medisolv, the company combines predictive intelligence with clinical expertise and healthcare quality improvement strategies.

5 investors

LillianCare addresses physician shortages in underserved rural and urban regions of Germany by redistributing primary care responsibilities among nurses and physician assistants within regulatory frameworks. The company redesigns general practice workflows to improve patient access and care efficiency in areas facing acute doctor shortages.

5 investors

Lotus.ai is building healthcare technology serving patients and clinicians. The company combines AI engineering with clinical expertise to develop fast and accessible care solutions.

5 investors

Lumata Health provides a Continuous Care program for eye care practices, helping patients stay on track with appointments and treatment adherence while addressing barriers to care. It supports ophthalmology and optometry practices in improving patient outcomes.

5 investors

Lumere, part of GHX, provides clinically integrated supply chain and value analysis tools that help healthcare providers reduce costs and variation through evidence-based product decisions and analytics. Its offering supports supply chain and clinical teams in hospitals with strategic sourcing, new product review workflows, and savings tracking.

5 investors

Lygos uses genetically engineered microorganisms to produce industrial chemicals from sugar feedstocks, focusing on compounds where fermentation offers cost advantages compared to fossil fuel-based manufacturing.

5 investors

MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.

5 investors

Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems. Its FDA 510(k)-cleared Steripath initial specimen diversion technology is used by clinical care teams to improve diagnostic accuracy for sepsis testing, primarily in the U.S.

5 investors

Irish company developing an advanced neurostimulation device.

5 investors